| Skin Cancer |
1 |
1 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.9 |
| Phototherapy |
0 |
0.55 |
| Cancer |
0 |
0.41 |
| Europe |
0 |
0.41 |
| Orphan Drugs |
0 |
0.41 |
| Healthcare and Medical Technology |
0 |
0.32 |
| Cutaneous T-Cell Lymphoma |
0 |
0.99 |
| Melanoma |
0 |
0.16 |
| Patient Safety |
0 |
0.16 |
| Psoriasis |
0 |
0.16 |
| Telehealth and Telemedicine |
0 |
0.16 |
| Adherence |
0 |
0.14 |
| Adverse Effects |
0 |
0.14 |
| Clinical Guidelines |
0 |
0.14 |
| Clinical Research |
0 |
0.14 |
| Grant |
0 |
0.14 |
| Lymphoma |
0 |
0.14 |
| Mycosis Fungoides |
0 |
0.14 |
| Pennsylvania |
0 |
0.14 |
| Ultraviolet Light |
0 |
0.14 |